Premium
Ex vivo analysis of HIV‐1 co‐receptors at the endocervical mucosa of women using oral contraceptives
Author(s) -
Prakash Manyu,
Patterson Steve,
Gotch Frances,
Kapembwa Moses S.
Publication year - 2004
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2004.00283.x
Subject(s) - chemokine receptor , chemokine , flow cytometry , medicine , cxcr4 , intraepithelial lymphocyte , cc chemokine receptors , immunology , receptor , gynecology , immune system
Combined oral contraceptives may alter the microenvironment of the female genital tract and, thus, influence susceptibility of endocervical cells to HIV‐1 transmission. The mechanism for this effect is unknown but might involve combined oral contraceptive up‐regulation of chemokine receptors on CD4 + endocervical cells. We measured chemokine co‐receptor (CCR5 and CXCR4) expression on cervical intraepithelial CD4 + T lymphocytes, macrophages and dendritic cells using flow cytometry in 32 healthy women, 16 of whom were combined oral contraceptive users and 16 non‐users. All women tested negative for sexually transmitted infections. Combined oral contraceptive users showed a higher proportion of CCR5 + CD4 + T lymphocytes compared with combined oral contraceptive non‐users ( P < 0.05). However, expression of both co‐receptors on cervical intraepithelial macrophages and dendritic cells was no different between the two groups. Up‐regulation of CCR5 on cervical intraepithelial CD4 + T lymphocytes offers a potential explanation by which women receiving combined oral contraceptives may be at increased risk of HIV transmission.